ArticleFrontiers in pharmacology2013

A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's disease.

Hugo Geerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.